Company Overview:
Dr. Reddy’s Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.
Financial Results:
Dr. Reddy’s Laboratories reported Total revenue for Q4FY25 of ₹ 9,050 Crore up from ₹7,311 Crore in Q4FY24, a rise of 24% y-o-y.
Total Expense for Q4FY25 of ₹7,050 Crore up from ₹5,709 Crore in Q4FY24, a rise of 23% y-o-y.
Net Profit of ₹1,593 Crore up 22% from ₹1,310 Crore in Q4FY24.
Earnings per Share is ₹19.12, up 21% from ₹15.73 in Q4FY24.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,